Non–small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology

…, A Tam, T Tanvetyanon, J Yanagawa, SC Yang… - Journal of the National …, 2022 - jnccn.org
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell Lung
Cancer (NSCLC) provide recommended management for patients with NSCLC, including …

[HTML][HTML] Neoadjuvant PD-1 blockade in resectable lung cancer

…, MD Hellmann, M Zahurak, SC Yang… - … England Journal of …, 2018 - Mass Medical Soc
Background Antibodies that block programmed death 1 (PD-1) protein improve survival in
patients with advanced non–small-cell lung cancer (NSCLC) but have not been tested in …

Non–small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology

…, J Stevenson, SJ Swanson, K Tauer, SC Yang… - Journal of the National …, 2017 - jnccn.org
This selection from the NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) focuses
on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic …

[HTML][HTML] DNA methylation markers and early recurrence in stage I lung cancer

…, K Pelosky, SA Belinsky, SC Yang… - … England Journal of …, 2008 - Mass Medical Soc
Background Despite optimal and early surgical treatment of non–small-cell lung cancer (NSCLC),
many patients die of recurrent NSCLC. We investigated the association between gene …

Non–small cell lung cancer

…, GR Simon, SJ Swanson, DE Wood, SC Yang - Journal of the national …, 2010 - jnccn.org
Lung cancer is the leading cause of cancer-related death in the United States. An estimated
219,440 new cases (116,090 men; 103,350 women) of lung and bronchus cancer were …

NCCN guidelines insights: non–small cell lung cancer, version 2.2021: featured updates to the NCCN guidelines

…, J Stevenson, A Tam, J Yanagawa, SC Yang… - Journal of the National …, 2021 - jnccn.org
Medicine (ACCME): NCCN designates this journal-based CME activity for a maximum of 1.0
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with …

NCCN guidelines insights: non–small cell lung cancer, version 1.2020: featured updates to the NCCN guidelines

…, SJ Swanson, KW Tauer, SC Yang… - Journal of the National …, 2019 - jnccn.org
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of
management for NSCLC. These NCCN Guidelines Insights focus on recent updates in …

Cigarette smoking is strongly associated with mutation of the K‐ras gene in patients with primary adenocarcinoma of the lung

…, EA Alawi, Y Zhu, M Sanchez‐Cespedes, SC Yang… - Cancer, 2001 - Wiley Online Library
BACKGROUND The majority of lung carcinoma cases occur in current or former smokers. K‐ras
gene mutations are common in lung adenocarcinoma and have been associated with …

Lung cancer screening, version 3.2018, NCCN clinical practice guidelines in oncology

…, DE Midthun, S Pipavath, C Pratt, C Reddy… - Journal of the National …, 2018 - jnccn.org
Lung cancer is the leading cause of cancer-related mortality in the United States and worldwide.
Early detection of lung cancer is an important opportunity for decreasing mortality. Data …

Non–small cell lung cancer, version 2.2013

…, SJ Swanson, K Tauer, DE Wood, SC Yang… - Journal of the National …, 2013 - jnccn.org
These NCCN Guidelines Insights focus on the diagnostic evaluation of suspected lung
cancer. This topic was the subject of a major update in the 2013 NCCN Clinical Practice …